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Abstract
Aim To investigate the effect of HO–CO on mortality
during septic shock in rats.
Method Eighty rats were randomly divided into group-
control, group ZnPP-IX, group SS, and group LZ.
Results Death was signiﬁcantly lower in group SS than in
group LZ (P\0.05). The MAP was signiﬁcantly higher in
the group LZ than in the group SS (P\0.05). ALT, AST,
Cr and BUN, MDA, and the lung EB contents, were sig-
niﬁcantly lower in the group SS than that in the group LZ
(all P\0.05). And CO and SOD activities were signiﬁ-
cantly higher in group SS than that in the group LZ (all
P\0.05). HO-1 mRNA, and HO-1 protein were signiﬁ-
cantly lower in the group LZ than in the group SS
(P\0.05), whereas HO-2 mRNA, and HO-2 protein
were not signiﬁcantly different among four groups (all
P[0.05).
Conclusion The increased oxidative stress and end-organ
damage is related to mortality during septic shock; while
the hypotension partly contributing to HO-1 protein and
CO has no obvious relation with it.
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Introduction
Septic shock is initiated by the release of bacterial cell
wall-derived lipopolysaccharide. If left unchecked, this
process may progress to refractory hypotension, multiple
organ system failure, and death. Beyond refractory hypo-
tension, oxygen-derived free radicals are believed to
contribute to the cellular and tissue injuries associated with
endotoxin-induced inﬂammation. Investigators have sug-
gested that this oxidative damage may be a major cause of
organ failure and mortality associated with sepsis [1] and
that the administration of antioxidants may be an adjuvant
to conventional therapy (such as vasoconstrictors) in the
management of sepsis [2, 3].
The heme oxygenases, which consist of inducible and
constitutive isozymes (HO-1, HO-2), catalyze the rate-
limiting step in the metabolic conversion of heme to the
bile pigments (i.e., biliverdin and bilirubin) and thus con-
stitute a major intracellular source of iron and carbon
monoxide (CO) [4]. HO-1 is a potentially important stress
response protein. HO-1 is induced not only by the substrate
heme but also by a variety of nonheme substance such as
heavy metals, endotoxin, heat shock, cytokines, and pros-
taglandins [4]. HO-1 and the subsequent metabolites of
heme catabolism appear to play vital roles in regulating
important biological responses, including inﬂammation,
oxidative stress, cell survival, and cell proliferation [4].
The proposed mechanisms by which HO-1 exerts its bio-
logical effects include its ability to degrade the pro-
oxidative heme, the release of biliverdin and subsequent
conversion to bilirubin, both of which have antioxidant
properties
, and the generation of CO, which has vasodila-
tory, antiproliferative, and anti-inﬂammatory properties
[4]. At the same time, investigators have provided evidence
that CO via the HO system may contribute to the regulation
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hypotensive response to LPS [5]. However, which is more
important in aforementioned two behaviors about HO-1
during septic shock is not very clear at present.
To better understand the role of HO-1 in the patho-
physiology of septic shock, we evaluated LPS-induced
shock and end-organ dysfunction in rats. The goal of the
present study was to deﬁne the role of HO-1 in LPS-
induced hypotension and to determine whether refractory
hypotension and/or exaggerated oxidative stress was
responsible for the mortality in septic shock rats by HO
activity inhibitor treatment.
Methods
Animal studies
Two-month-old male Sprague-Dawley rats (160–185 g)
were purchased from the Laboratory Animal Center of
Tongji Medical College. Only ﬁve animals were housed in
the same cage, acclimatized to a 12-h light-dark cycle and
allowed free access to food and water for a 5-day period
prior to the experimental procedure. During the experi-
ments, the environmental temperature was maintained
between 23 and 25C. The experimental protocol was
approved by the local animal care and use committee, and
all animals received humane care according to the criteria
outlined in the ‘‘Guide for the Care and Use of Laboratory
Animals’’ prepared by the National Academy of Sciences
and published by the National Institutes of Health (NIH
publication 86-23, revised 1985).
Rats were fasted for 12 h, but allowed free access to
water before the induction of anesthesia. The rats received
an intraperitoneal injection of 20% urethane (1.5 g/kg) that
kept them anesthetized throughout the experiment. The
right carotid artery and the intra-jugular vein were cannu-
lated with PE-50 tubing to monitor the mean arterial
pressure (MAP) using Hellige monitor instruments (Ger-
many), and with a 24-g cannula for intravenous injections.
Subsequently, the animals were heparinized with 500 U/
kg heparin.
Eighty rats were randomly divided into four groups: C
group (n = 20), Z group (n = 20), SS group (n = 20) and
LZ group (n = 20). Groups C and Z received 0.5 ml nor-
mal saline intravenously, while groups SS and LZ both
received 0.5 ml (10 mg/kg) LPS(O111B4, Sigma, USA) to
replicate the experimental model of septic shock. After an
initial 25% decrease in the MAP, group LZ received 1 ml
(10 lmol/kg, intraperitoneally) zinc protoporphyrin-IX
(ZnPP-IX, Sigma, USA), while group SS received 1 ml
50 mM sodium bicarbonate vehicle in place of ZnPP-IX.
Two hours after injecting normal saline intravenously,
group Z received 1 ml (10 lmol/kg, intraperitoneally)
ZnPP-IX, while group C received 1 ml 50 mM sodium
bicarbonate vehicle instead. The rats received 0.5 ml of
30 mg/kg Evans blue (EB, Serva, Germany) intravenously
5 min before administering the LPS or normal saline. MAP
was monitored continuously, and if the MAP did not
decrease within 2 h, the animal was excluded from the
study.
Monitoring and recording indexes
MAP and ECG were monitored continuously throughout
the experiment. The MAP was recorded after the induction
of the septic shock at 30, 60, 90 and 120 min. And the
deaths within 7 h were recorded.
Sampling and storage
The blood samples were collected 7 h after LPS adminis-
tration in a living rat or in a dying rat having an ECG
displaying HR B 20 beats/min, or a ventricular ﬂutter, or a
ventricular ﬁbrillation, and centrifuged at 4,000 rpm for
10 min at 4C. The rats were killed, and their femoral
artery, liver, lung, and kidney were removed, and quickly
perfused with phosphate-buffered saline to remove the
blood. The blood samples and the remaining tissues after
perfusion and rinsing were frozen in liquid nitrogen and
stored at -70C until assayed.
Biochemical measurements
Alanine aminotransferase (ALT), aspartate aminotransfer-
ase (AST), creatinine (Cr), and blood urea nitrogen (BUN)
levels in the plasma were measured with a Hitachi7060
Fully Automated Biochemistry Analyzer (Japan). Hepatic,
renal and pulmonary superoxide dismutase (SOD) activity,
and malondialdehyde (MDA), contents were determined by
spectrophotometry [6] and by the method of Ohkawa et al.
[7], respectively. SOD activity and MDA contents were
expressed as per unit of protein determined by the Lowry
method [8].
Measurement of Evans blue contents
The right lung was weighed and then incubated in form-
amide for 18 h at 37C to extract the EB dye. The left lung
was weighed and then dried in an oven at 55C, and the wet-
to-dry weight ratio from that lung was used to estimate the
dry weight of the right lung. The extracted dye was quan-
titated in a spectrophotometer by measuring the absorbance
at 620 nm and comparing to standards of EB dye dissolved
in formamide. The EB dye extravasation was expressed as
nanograms of EB dye per milligram of dry tissue.
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123Measurement of CO in plasma
CO level in plasma was determined by the method of
Chalmers AH [9], and was expressed as milligram of CO
per liter of fresh blood.
RNA extraction and reverse transcription (RT)-PCR
Total RNA was extracted from the femoral artery, liver,
kidney, and lung by employing a Total Quick RNA kit
(TA200TQR, Talent, Italy). The ethanol-precipitated RNA
fraction (1 lg) was reverse transcribed using a Revert
Aid
TM First Strand cDNA Synthesis kit (MetaBios Inc.,
Canada), according to the manufacturer’s protocol, and
50 lL of ﬁrst-strand cDNA solution was obtained. The
primers used in this study were 50-CGACAGCATGTCC
CAGGATT-30 and 50-TCGCTCTATCTCCTCTTCCAGG-30
for rat HO-1, 160 bp; 50-TTCTACCTGTTCGAGCATG
TGG-30 and 50-TGTTAGCATGGAGCCAGCCT-30 for rat
HO-2, 180 bp; 50-CCTAAGGCCAACCGTAAAG-30 and
50-TCTTCATGGTGCTAGGAGCCA-30 for rat ß-actin,
623 bp. RT-PCR was performed as described by Hidenori
Suzuki et al. [10]. The integral optical density (IOD) of the
DNA bands was measured with a Shanghai Sixing Image
Analysis System. The IOD ratio of HO-1,or HO-2, and ß-
actin was calculated, and used as an expression of HO-1
mRNA or HO-2 mRNA.
Western blot analysis
Tissue samples were homogenized in 13.2 mmol/L Tris–
HCl, 5.5% glycerol, 0.44% SDS, and 10% ß-mercap-
toethanol. An equal amount of extracted soluble protein
(50 lg) was fractionated by Tris–glycine–SDS–polyacryl-
amide gel (12%) electrophoresis, and Western blotting was
performed as described [11] with use of a polyclonal rabbit
antibody to recombinant rat HO-1 or HO-2 protein
(1:1,000, Santa Cruz, USA). The IOD of protein bands
were measured with a LEICA-550IW Image Analysis
System. The product of IOD and the area was as an
expression of HO-1 protein (or HO-2 protein).
Statistical analysis
All data were expressed as mean ± standard deviation
(SD). Comparisons of mortality between groups were made
by the v
2 goodness of ﬁt test, and intergroup comparisons
among the four groups were determined by one-way
ANOVA. When the F value was signiﬁcant (P\0.05), a
post hoc analysis was performed with the Duncan new
multiple range test in order to test the difference between
means. P\0.05 was considered statistically signiﬁcant.
Results
Deaths
The death rate in group SS (13 animals) was lower than
that in the LZ group (19 animals) (P\0.05), and was
higher than that in groups C (zero animal) and Z (zero
animal) (all P\0.05), respectively. There was no signiﬁ-
cant difference in death rate between C group and Z group
(P[0.05).
Comparisons of MAP
The changes of MAP among the four groups are shown in
Table 1. Sixty minutes after septic shock, the MAP in the
LZ group was signiﬁcantly higher than that in the SS group
(all P\0.05), and lower than that in groups C and Z (all
P\0.05). There was no signiﬁcant difference between the
C group and the Z group (P[0.05).
Comparisons of CO, Cr and Bun concentrations, ALT
and AST activities, and lung EB contents
The comparisons of the CO, Cr and BUN concentrations,
ALTandASTactivities,andEBcontentsamongfourgroups
are shown in Table 2. The CO concentration in group LZ
was signiﬁcantly lower than that in group SS (P\0.05),
and greater than that in group C and Z, respectively (all
P\0.05). The Cr and BUN concentrations, ALT and AST
Table 1 Changes of MAP by ZnPP-IX or NaHCO3 treatment in four groups ð x   s; n ¼ 20Þ
Basic MAP Before treatment MAP (mmHg) After treatment MAP (mmHg)
30 min 60 min 90 min 120 min
C 99.6 ± 12.2 98.1 ± 11.1* 97.1 ± 12.1* 97.8 ± 11.8* 98.6 ± 11.7* 99.1 ± 10.7*
Z 100.1 ± 10.9 98.8 ± 10.5* 97.4 ± 11.3* 99.0 ± 10.6* 99.3 ± 10.5* 98.2 ± 12.7*
SS 99.1 ± 11.7 72.2 ± 9.3 70.1 ± 9.2 67.1 ± 7.8* 65.1 ± 7.3* 63.4 ± 6.8*
LZ 98.8 ± 11.5 72.8 ± 9.0 70.6 ± 8.5 72.3 ± 7.3 73.3 ± 6.9 74.5 ± 7.6
* Indicates test group signiﬁcantly different from LZ group (one-way ANOVA, P\0.05)
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123activities, and lung EB contents in group SS were signiﬁ-
cantlylowerthanthatingroupLZ(allP\0.05),andgreater
than that in groups C and Z, respectively (all P\0.05).
There were no signiﬁcant differences in six indices between
the C group and the Z group (all P[0.05).
Comparisons of MDA contents and SOD activity
The comparisons of the MDA contents and SOD activity in
kidney, lung and liver among four groups is shown in
Table 3. The nephric, pulmonary, and hepatic MDA con-
tents in groups SS were signiﬁcantly lower than that in the
LZ group (all P\0.05), and greater than that in the groups
C and Z (all P\0.05). The SOD activity was reverse in
the four groups, respectively. There were no signiﬁcant
differences in MDA contents and SOD activity between
groups C and Z (all P[0.05).
Comparisons of HO-1 mRNA, HO-2 mRNA,
HO-1 protein, and HO-2 protein expression
The comparisons of HO-1 mRNA, HO-2 mRNA, HO-1
protein, and HO-2 protein in femoral arterial, nephric,
pulmonary, and hepatic tissue are shown in Tables 4 and 5,
and Figs. 1, 2, 3, 4, 5, 6, 7 and 8. The HO-1 mRNA and
HO-1 protein of femoral arterial, nephric, pulmonary, and
hepatic tissue in groups LZ were lower than that in group
SS (all P\0.05), and greater than that in groups C and Z
(all P\0.05). There were no signiﬁcant differences
between groups C and Z (all P[0.05). The HO-2 mRNA
and HO-2 protein among four groups were not signiﬁcantly
different (all P[0.05).
Discussion
In the present study, the role of HO–CO on septic shock in
rats was investigated. The principal ﬁnding of this study
was that the upregulation of HO-1 protein followed by CO
increasing could reduce the mortality during septic shock,
while the hypotension partly contributing to HO-1 protein
and CO has no obvious relation with it.
Immunocytochemical staining localizes an increase in
HO-1 protein within smooth muscle cells of both large
(aorta) and small (arterioles) blood vessels, and the induc-
tion of HO and subsequent CO could reduce vascular tone
during septic shock [12]. To clarify the role of HO induction
in septic shock, we administered ZnPP-IX to rats that were
made hypotensive by LPS. We used ZnPP-IX instead of
other metalloporphyrins to inhibit HO activity because
ZnPP-IX has been shown to be selective for HO over other
microsomal enzymes [13]. To avoid effect of ZnPP-IX on
NOS activity and soluble guanylyl cyclase activity in vas-
cular endothelial cells, ZnPP-IX was given in a dose of
10 lmol/kg [12] in this study. In our experiments, ZnPP-IX
abrogatedtheLPS-inducedhypotension,anditincreasedthe
mortality.Atthesametime,HO-1mRNA,andHO-1protein
in femoral artery and plasma CO dramatically decreased.
Downregulation of HO-1 protein by ZnPP-IX in septic
shock was found in the liver, lung, and kidney resulting in a
Table 2 Comparisons of the Cr and BUN concentrations, ALT and AST activities, and EB contents among four groups ð x   s; n ¼ 20Þ
Cr(lmol/L) BUN (mmol/L) ALT (U/L) AST (U/L) EB (ng/mg) CO (mg/L)
C 92.4 ± 12.3* 5.9 ± 1.3* 37.7 ± 7.3* 49.1 ± 9.1* 46.7 ± 9.5* 0.45 ± 0.06*
Z 94.9 ± 11.7* 6.1 ± 1.2* 39.2 ± 6.9* 51.6 ± 8.7* 48.2 ± 8.7* 0.43 ± 0.08*
SS 120.8 ± 19.1 11.5 ± 2.6 66.9 ± 12.0 105.3 ± 12.2 230.4 ± 44.8 0.84 ± 0.14
LZ 135.5 ± 20.8* 13.4 ± 2.0* 77.1 ± 12.8* 115.1 ± 14.9* 270.6 ± 51.9* 0.70 ± 0.11*
* Indicates test group signiﬁcantly different from SS group (one-way ANOVA, P\0.05)
Table 3 Comparisons of the
MDA contents and SOD
activity in kidney, lung, and
liver among four groups
ð x   s; n ¼ 20Þ
* Indicates test group
signiﬁcantly different from SS
group (1-way ANOVA,
P\0.05)
C Z SS LZ
Kidney
MDA (nmol/mg protein) 1.57 ± 0.54* 1.59 ± 0.51* 2.63 ± 0.66 3.57 ± 0.78*
SOD (NU/mg protein) 28.4 ± 2.12* 27.7 ± 2.38* 14.4 ± 1.89 12.2 ± 1.67*
Lung
MDA (nmol/mg protein) 1.79 ± 0.55* 1.83 ± 0.52* 3.62 ± 0.92 4.33 ± 1.12*
SOD (NU/mg protein) 30.9 ± 4.4* 31.2 ± 4.1* 16.8 ± 2.04 14.2 ± 1.84*
Liver
MDA (nmol/mg protein) 9.76 ± 1.27* 10.1 ± 1.12* 15.5 ± 2.3 17.4 ± 2.9*
SOD (NU/mg protein) 68.1 ± 12.9* 66.4 ± 13.5* 42.1 ± 10.3 32.6 ± 7.2*
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123increasing of the end-organ dysfunctions, and meanwhile
CO concentration and SOD activity reduced, and MDA
contents and pulmonary vascular leakage increased. Chae
and colleagues [14] demonstrated that the inhibition of
HO-1 with using the HO-1 inhibitor ZnPP or HO-1 siRNA
resulted in a striking increase of apoptosis in the CO/TNF-
alpha-treated cells. Barrera et al. [15] suggested that HO-1
Table 4 The comparison of HO-1mRNA and HO-2mRNA expression in the femoral arterial, hepatic, renal, and pulmonary tissue among four
groups ð x   s; n ¼ 20Þ
HO-1mRNA HO-2mRNA
C Z SS LZ C Z SS LZ
Femoral artery 0.73 ± 0.10* 0.71 ± 0.09* 1.46 ± 0.14* 1.10 ± 0.16 0.97 ± 0.08 0.99 ± 0.08 1.02 ± 0.08 1.02 ± 0.08
Kidney 0.81 ± 0.12* 0.79 ± 0.10* 1.33 ± 0.15* 1.07 ± 0.13 1.02 ± 0.08 0.98 ± 0.09 0.97 ± 0.08 1.03 ± 0.09
Lung 0.74 ± 0.11* 0.72 ± 0.10* 1.51 ± 0.19* 1.03 ± 0.14 1.01 ± 0.07 0.99 ± 0.06 1.02 ± 0.07 0.98 ± 0.05
Liver 0.69 ± 0.13* 0.71 ± 0.11* 1.56 ± 0.17* 1.04 ± 0.16 0.99 ± 0.06 0.98 ± 0.05 1.01 ± 0.07 1.02 ± 0.08
* Indicates test group signiﬁcantly different from LZ group (1-way ANOVA, P\0.05)
Table 5 The comparison of HO-1 protein and HO-2 protein expression in the femoral arterial, hepatic, renal, and pulmonary tissue among four
groups ð x   s; n ¼ 20Þ
HO-1 protein HO-2 protein
C Z SS LZ C Z SS LZ
Femoral artery 4.12 ± 1.06** 4.17 ± 1.04* 8.53 ± 2.27* 6.51 ± 1.68 3.83 ± 1.13 3.78 ± 1.10 3.82 ± 1.10 3.92 ± 0.98
Kidney 3.61 ± 1.11* 3.57 ± 1.13* 6.88 ± 1.29* 5.49 ± 1.20 3.21 ± 1.07 3 .14 ± 1.00 3.25 ± 1.09 3.18 ± 1.02
Lung 3.93 ± 0.99* 3.89 ± 0.98* 9.78 ± 1.93* 6.97 ± 1.67 3.49 ± 1.07 3.46 ± 1.05 3.54 ± 1.03 3.58 ± 1.07
Liver 4.29 ± 1.13* 4.21 ± 1.16* 11.56 ± 2.17* 9.44 ± 1.56 3.59 ± 1.16 3.61 ± 1.10 3.72 ± 1.07 3.67 ± 1.11
* Indicates test group signiﬁcantly different from LZ group (1-way ANOVA, P\0.05)
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Fig. 1 Western blotting analysis of HO-1 protein in femoral arterial
tissue
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Fig. 2 Western blotting analysis of HO-2 protein in femoral arterial
tissue
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Fig. 3 Western blotting analysis of HO-1 protein in nephric tissue
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Fig. 4 Western blotting analysis of HO-2 protein in nephric tissue
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Fig. 5 Western blotting analysis of HO-1 protein in pulmonary tissue
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Fig. 6 Western blotting analysis of HO-2 protein in pulmonary tissue
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Fig. 7 Western blotting analysis of HO-1 protein in hepatic tissue
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123overexpression induced by SnCl2 is responsible for the
attenuation of renal damage and oxidative stress induced
by potassium dichromate. The protective mechanisms of
HO-1 may be its augmentation of iron efﬂux, reﬂecting a
role for HO-1 in modulating intracellular iron levels and
regulating cell viability [4]. Bilirubin and biliverdin which
are two metabolites of heme degradation, act as scavengers
of toxic oxygen radicals. Bilirubin is a strong antioxidant in
mammals [16]. CO, a metabolite of heme degradation, can
negatively feed back NO generation [4], which can be
cytotoxic because of its strong oxidation potential.
This investigation indicated that mortality increased
signiﬁcantly after the septic shock rats treated by ZnPP-IX.
ZnPP-IX abrogated the LPS-induced hypotension. The
levels of plasma ALT, AST, Cr and BUN, MDA of liver,
kidney and lung, and the lung EB contents were signiﬁ-
cantly increased, while the SOD activity of liver, kidney
and lung, and CO of plasma were reduced. These results
indicated that ZnPP-IX treatment could increase MAP and
deteriorate the function of liver, kidney, and lung.
Taken together, the increased oxidative stress and end-
organ (renal, pulmonary and hepatic) damage is related to
the mortality during septic shock, while the hypotension
partly contributing to HO-1 protein and CO has no obvious
relation with it. These data also suggest that it is unsuitable
to correct refractory hypotension by restraining the HO–
CO system.
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